SGH
BIO icon

Sivik Global Healthcare’s Bio-Rad Laboratories Class A BIO Stock Holding History

Sivik Global Healthcare’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.79M Hold
10,000
– – 2.12% 25
2026
Q1 		$2.79M Sell
10,000
-2,000
-17% -$576K 2.12% 25
2025
Q4 		$3.64M Buy
12,000
+1,000
+9% +$312K 1.06% 36
2025
Q3 		$3.08M Sell
11,000
-7,000
-39% -$1.9M 0.9% 39
2025
Q2 		$4.34M Buy
+18,000
New +$4.26M 1.18% 33
2025
Q1 		– Sell
-10,000
Closed -$3.29M – 35
2024
Q4 		$3.29M Buy
+10,000
New +$3.39M 1.73% 27
2021
Q2 		– Sell
-6,500
Closed -$3.71M – 51
2021
Q1 		$3.71M Sell
6,500
-1,500
-19% -$888K 1.35% 35
2020
Q4 		$4.66M Buy
8,000
+500
+7% +$285K 1.9% 30
2020
Q3 		$3.87M Buy
+7,500
New +$3.8M 1.66% 31
2020
Q1 		– Sell
-15,000
Closed -$5.55M – 43
2019
Q4 		$5.55M Sell
15,000
-3,000
-17% -$1.06M 2.06% 25
2019
Q3 		$5.99M Buy
18,000
+500
+3% +$163K 3.02% 12
2019
Q2 		$5.47M Sell
17,500
-2,500
-13% -$749K 1.32% 20
2019
Q1 		$6.11M Buy
20,000
+7,500
+60% +$2.02M 2.25% 13
2018
Q4 		$2.9M Sell
12,500
-7,500
-38% -$2.01M 1.56% 30
2018
Q3 		$6.26M Buy
20,000
+2,500
+14% +$776K 2.23% 18
2018
Q2 		$5.05M Buy
17,500
+2,500
+17% +$690K 1.94% 23
2018
Q1 		$3.75M Buy
15,000
+2,500
+20% +$637K 1.75% 25
2017
Q4 		$2.98M Buy
12,500
+2,500
+25% +$606K 1.11% 44
2017
Q3 		$2.22M Buy
+10,000
New +$2.25M 0.76% 51

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Sivik Global Healthcare's BIO Position: Q2 2026 in Review

Sivik Global Healthcare held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 10,000 shares worth $2.79M. The position accounts for 2.12% of the portfolio, ranked #25.

Sivik Global Healthcare first reported a position in BIO in Q3 2017 and has held it in 19 quarters since. The position peaked at $6.26M in Q3 2018. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Sivik Global Healthcare held 10,000 shares of Bio-Rad Laboratories Class A worth $2.79M as of Q2 2026.
  • Sivik Global Healthcare left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
  • Bio-Rad Laboratories Class A made up 2.12% of Sivik Global Healthcare's portfolio in Q2 2026, its #25 holding.
  • Sivik Global Healthcare first reported a position in Bio-Rad Laboratories Class A in Q3 2017 and has held it in 19 quarters since.
  • Sivik Global Healthcare's Bio-Rad Laboratories Class A position peaked at $6.26M in Q3 2018.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Sivik Global Healthcare's 13F filing for Q2 2026, filed 20 Jul 2026.